Go to deals
Business Support Services | Healthcare | Private Equity

High Select has been acquired by The AccelerationGroup

September 2012 — High Select has established a strategic partnership with the AccelerationGroup in which the AccelerationGroup acquired a majority stake in High Select and where the owners of High Select keep a remaining minority stake. The sellers will stay on their management position within the company. Financial details have not been disclosed.

High Select offers non-patient related traineeships to companies operating in the healthcare sector. The company selects and recruits students and employs these at companies operating in the healthcare sector requesting temporary management assistance. The shareholders believe that there is significant potential for the company to grow, but it is currently restricted by a lack of capital. The shareholders were looking for an external party with both sufficient resources and industry knowledge to help further develop the company.

The AccelerationGroup, founded and managed by Gerd Koops and Lars Spannenburg, advises companies with unique business challenges in the broadest sense of the word.

Our role in the transaction

Oaklins' small cap advisory team in the Netherlands helped High Select to find a strategic or financial partner who was able to further strengthen commercial activities and already had a well-established network within the healthcare sector. In addition, the partner would be able to provide additional growth capital. Our team identified The AccelerationGroup as the right fit for a strategic partnership.

Parties

Talk to the deal team

Frederik van der Schoot

Managing Partner
Amsterdam, Netherlands
Oaklins Netherlands

Adse de Kock

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Tom Snijckers

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Related deals

Comtax has been acquired by Ryan
Private Equity | Business Support Services | TMT

Comtax has been acquired by Ryan

Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.

Learn more
Cibus has acquired Aweta from Standard Investment
Private Equity | Agriculture | Industrial Machinery & Components

Cibus has acquired Aweta from Standard Investment

Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.

Learn more
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Healthcare

Katalyst Diagnostics has been acquired by Cruinn Diagnostics

Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.

Learn more